Brief: Purapharm Expects Group's Revenue For HY Will Record Decrease Of About 15%
19/07/2019 13:17
July 19 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* EXPECTS GROUP'S REVENUE FOR HY WILL RECORD DECREASE OF
ABOUT 15%
* EXPECTS GROUP FOR HY TO RECORD SUBSTANTIAL NET LOSS
* CHANGE FROM PROFIT DUE TO DECREASE IN SALES OF GROUP'S
CHINA
CONCENTRATED CHINESE MEDICINE GRANULES SEGMENT AND PLANTATION
SEGMENT
Source text for Eikon: ID:nHKS2lQR2h
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln